Drug Makers Shifting Towards Targeted Cancer Drugs

The continuing shift away from one-size-fits-all cancer treatments will be on display this week when a medical society releases clinical data for drugs that target unique molecular features of cancer cells.





Pfizer Inc. , GlaxoSmithKline PLC (GSK, GSK.LN) and Johnson & Johnson are among those whose drugs will be highlighted when the American Society of Clinical Oncology on Wednesday releases summaries of more than 4,500 cancer studies, two weeks ahead of ASCO's annual scientific meeting.

Read the full story: http://hcp.lv/L7lWOL

Source: Market Watch (The Wall Street Journal)